| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Leducq Center for Cardiovascular Research, Cardiovascular Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts
T lymphocytes localize within lesions of two diametrically opposed expressions of atherosclerosis: stenosis-producing plaques and ectasia-producing abdominal aortic aneurysm (AAA). TH1 immune responses appear to predominate in human stenotic lesions. However, little information exists regarding the nature of the T-cell infiltrate in AAAs. We demonstrate here that AAAs predominantly express TH2-associated cytokines and correspondingly lack mediators associated with the TH1 response as determined by Western blot and immunohistochemical analysis. In particular, aneurysmal tissue expressed interleukin (IL)-4, IL-5, and IL-10, cytokines not or only faintly detected in nondiseased tissue or stenotic atheroma. In contrast, AAAs contained low levels of the TH1 characteristic cytokines IL-2 and IL-15, which are amply expressed in stenotic lesions. Notably, stenotic lesions, but not AAAs, contained mature forms of the interferon-
-inducing cytokines IL-12 and IL-18 as well as the IL-18-processing enzyme caspase-1. Moreover, aneurysmal tissue lacked the receptor for interferon-
, although both types of lesions contained this TH1-promoting cytokine. These findings suggest that the functional repertoire of T cells differs in stenotic and aneurysmal lesions, and provide a novel framework for understanding the mechanisms of these diametrically opposite expressions of atherosclerosis.
This article has been cited by other articles:
![]() |
P. Libby, P. M. Ridker, G. K. Hansson, and for the Leducq Transatlantic Network on Atherothro Inflammation in Atherosclerosis: From Pathophysiology to Practice J. Am. Coll. Cardiol., December 1, 2009; 54(23): 2129 - 2138. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miyake and R. Morishita Pharmacological treatment of abdominal aortic aneurysm Cardiovasc Res, August 1, 2009; 83(3): 436 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. King, A. Y. Lin, F. Kristo, T. J.T. Anderson, N. Ahluwalia, G. J. Hardy, A. P. Owens III, D. A. Howatt, D. Shen, A. M. Tager, et al. Interferon-{gamma} and the Interferon-Inducible Chemokine CXCL10 Protect Against Aneurysm Formation and Rupture Circulation, January 27, 2009; 119(3): 426 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Ruddy, J. A. Jones, F. G. Spinale, and J. S. Ikonomidis Regional heterogeneity within the aorta: Relevance to aneurysm disease. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1123 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sampi, O. Ukkola, M. Paivansalo, Y. A. Kesaniemi, C. J. Binder, and S. Horkko Plasma Interleukin-5 Levels Are Related to Antibodies Binding to Oxidized Low-Density Lipoprotein and to Decreased Subclinical Atherosclerosis J. Am. Coll. Cardiol., October 21, 2008; 52(17): 1370 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schulte, G. K. Sukhova, and P. Libby Genetically Programmed Biases in Th1 and Th2 Immune Responses Modulate Atherogenesis Am. J. Pathol., June 1, 2008; 172(6): 1500 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuivaniemi, C. D. Platsoucas, and M. D. Tilson III Aortic Aneurysms: An Immune Disease With a Strong Genetic Component Circulation, January 15, 2008; 117(2): 242 - 252. [Full Text] [PDF] |
||||
![]() |
V. L. King, L. A. Cassis, and A. Daugherty Interleukin-4 Does Not Influence Development of Hypercholesterolemia or Angiotensin II-Induced Atherosclerotic Lesions in Mice Am. J. Pathol., December 1, 2007; 171(6): 2040 - 2047. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.R.S. Girn, N.M. Orsi, and S. Homer-Vanniasinkam An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease Vascular Medicine, November 1, 2007; 12(4): 299 - 309. [Abstract] [PDF] |
||||
![]() |
R. N. Mitchell and P. Libby Vascular Remodeling in Transplant Vasculopathy Circ. Res., April 13, 2007; 100(7): 967 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Houard, A. Leclercq, V. Fontaine, M. Coutard, J.-L. Martin-Ventura, B. Ho-Tin-Noe, Z. Touat, O. Meilhac, and J.-B. Michel Retention and Activation of Blood-Borne Proteases in the Arterial Wall: Implications for Atherothrombosis J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A3 - A9. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shimizu, R. N. Mitchell, and P. Libby Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 987 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 671 - 678. |
||||
![]() |
G. Caligiuri, P. Rossignol, P. Julia, E. Groyer, D. Mouradian, D. Urbain, N. Misra, V. Ollivier, M. Sapoval, P. Boutouyrie, et al. Reduced Immunoregulatory CD31+ T Cells in Patients With Atherosclerotic Abdominal Aortic Aneurysm Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 618 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Debret, F. Antonicelli, A. Theill, W. Hornebeck, P. Bernard, M. Guenounou, and R. Le Naour Elastin-Derived Peptides Induce a T-Helper Type 1 Polarization of Human Blood Lymphocytes Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1353 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.E. Norman and J.T. Powell Vitamin D, Shedding Light on the Development of Disease in Peripheral Arteries Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 39 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xiong, Y. Zhao, A. Prall, T. C. Greiner, and B. T. Baxter Key Roles of CD4+ T Cells and IFN-{gamma} in the Development of Abdominal Aortic Aneurysms in a Murine Model J. Immunol., February 15, 2004; 172(4): 2607 - 2612. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Steinmetz, C. Buckley, and R. W. Thompson Prospects for the Medical Management of Abdominal Aortic Aneurysms Vascular and Endovascular Surgery, May 1, 2003; 37(3): 151 - 163. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |